Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase

Timothy L. Frankel, William R. Burns, Peter D. Peng, Zhiya Yu, Dhanalakshmi Chinnasamy, Jennifer A. Wargo, Zhili Zheng, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase'. Together they form a unique fingerprint.

Medicine & Life Sciences